Home
Conditions
NSCLC (Non-small Cell Lung Cancer)

Clinical trial condition

NSCLC (Non-small Cell Lung Cancer)

Explore clinical trials studying NSCLC (Non-small Cell Lung Cancer). Study availability and eligibility vary by location and protocol.

53 public trials 33 recruiting studies

Refine in advanced search Browse all conditions

NSCLC (Non-small Cell Lung Cancer) trial results

Recruiting

A Phase 1/1b Study of IAM1363 in HER2 Cancers

NCT06253871

Conditions: Brain Diseases, Brain Metastases From HER2 and Breast Cancer, Brain Metastases From Solid Tumors, +36 more
Locations: UCSD Moores Cancer Center La Jolla, California, United States

USC Norris Comprehensive Cancer Center Los Angeles, California, United States

University of Colorado Cancer Center Aurora, Colorado, United States

University of Miami Miami, Florida, United States

View all 53 locations

View Trial Details

Recruiting

Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas

NCT05751798

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +16 more
Locations: Institut Jules Bordet Anderlecht, Belgium

Antwerp University Hospital Edegem, Belgium

Centre Léon Bérard Lyon, France

Hopital Saint Joseph Paris, France

View Trial Details

Recruiting

Serplulimab Monotherapy in Elderly Patients With NSCLC and PD-L1 TPS ≥ 50%

NCT07596121

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Tangdu Hospital Affiliated to the Fourth Military Medical University Xi'an, Shannxi, China

View Trial Details

Recruiting

Microwave Ablation Plus Tislelizumab and Docetaxel in Advanced NSCLC After First-Line Immunotherapy Failure

NCT07528274

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Tianjin Cancer Hospital Airport Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Neoadjuvant Therapy With Ensartinib Combined With Chemotherapy for ALK-positive Non - Small Cell Lung Cancer (NSCLC)

NCT07354061

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Tangdu Hospital Xi’an, Shanxi, China

View Trial Details

Recruiting

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

NCT07189871

Conditions: Adnexal Diseases, Breast Diseases, Breast Neoplasms, +60 more
Locations: Dothan Hematology & Oncology Dothan, Alabama, United States

BAMF Health Grand Rapids, Michigan, United States

Nebraska Cancer Specialists Omaha, Nebraska, United States

XCancer Omaha, Nebraska, United States

View Trial Details

Recruiting

Early Feasibility Study (EFS) of the 'CAROL' for Treatment of Lung Cancer Stage 1

NCT07122258

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Royal Melbourne Hospital Melbourne, Victoria, Australia

View Trial Details

Recruiting

Single-Fraction Pulmonary Ablative Radiotherapy Outcomes and Quality-of-life Workup

NCT07441941

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: Montpellier Cancer Institut Montpellier, ICM, France

Lorraine Cancer Institute Vandœuvre-lès-Nancy, France

View Trial Details

Recruiting

A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors

NCT07376707

Conditions: Adenocarcinoma, Bronchial Neoplasms, CRC (Colorectal Cancer), +36 more
Locations: Fudan University Shanghai Cancer Center Shanghai, China

View Trial Details

Recruiting

WAST Cell-Docetaxel Combination Therapy in PD-1 Inhibitor-Resistant Advanced NSCLC

NCT07330050

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China

View Trial Details

NSCLC (Non-small Cell Lung Cancer)

NSCLC (Non-small Cell Lung Cancer) trial results

Related conditions